Trade APMD stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Apnimed, Inc. (APMD) is trading at US$21.88, up 1.70% today as of Oct 5, 14:22 EDT. The company has a market capitalisation of US$1.12B. Over the past 52 weeks, APMD has traded between US$16.00 and US$35.29. On Syfe you can trade APMD with $0 commission and add it to your watchlist.
| Previous close | US$21.51 |
|---|---|
| Market cap | US$1.12B |
| 52-week range | US$16.00 – US$35.29 |
| Volume | 682.09K |
| Exchange | US |
Apnimed, Inc.
Apnimed, Inc. operates as a clinical-stage company. It engages in the discovery, development, and commercialization of oral therapies for sleep-related breathing diseases. The company was founded by Lawrence G. Miller, Barry Wohl and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.
Year: 2026
--LifeSci Capital Initiates Coverage on Apnimed With Outperform Rating, $50 Price Target
Aug 25, 11:08 AM · MT Newswires
--Cantor Fitzgerald Initiates Coverage on Apnimed With Overweight Rating, $60 Price Target
Aug 25, 11:07 AM · MT Newswires
--Cantor Fitzgerald Initiates Apnimed at Overweight With $60 Price Target
Aug 25, 10:51 AM · MT Newswires
--LifeSci Capital Initiates Apnimed at Outperform With $50 Price Target
Aug 25, 10:46 AM · MT Newswires
Apnimed, Inc. (APMD) stock is trading at US$21.88, +1.70% from the previous close of US$21.51.
The market cap for Apnimed, Inc. (APMD) stock is approximately US$1.12B.
The 52-week high for Apnimed, Inc. (APMD) stock is US$35.29.
The 52-week low for Apnimed, Inc. (APMD) stock is US$16.00.
Apnimed, Inc. (APMD) does not currently pay a dividend.
Stay on top of APMD
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
